Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for SRPT

Stock NameSarepta Therapeutics Inc
TickerSRPT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS8036071004
LEI549300IKDPIED8J8IG21

Show aggregate SRPT holdings

News associated with SRPT

Leerink Partners Boosts Sarepta Therapeutics (NASDAQ:SRPT) Price Target to $15.00
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target raised by analysts at Leerink Partners from $12.00 to $15.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “market perform” rating on the biotechnology company’s stock. Leerink Partners’ price target would indicate a potential downside of 12.89% from the stock’s […] - 2025-09-11 03:04:49
After Hours Most Active for Aug 29, 2025 : ELAN, NVDA, GOOG, PPBI, SRPT, COLB, MSFT, SNAP, KMI, XOM, NEE, PFE
The NASDAQ 100 After Hours Indicator is down -7.17 to 23,408.25. The total After hours volume is currently 173,977,891 shares traded.The following are the most active stocks for the after hours session: Elanco Animal Health Incorporated (ELAN) is unchanged at $18.35, with 22,912 - 2025-08-29 17:29:12
HC Wainwright Reiterates “Sell” Rating for Sarepta Therapeutics (NASDAQ:SRPT)
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “sell” rating reiterated by equities research analysts at HC Wainwright in a report released on Monday,Benzinga reports. A number of other research firms have also issued reports on SRPT. Barclays raised shares of Sarepta Therapeutics from an “underweight” rating to an “equal weight” rating and […] - 2025-08-27 02:30:45
SCHK's Underlying Holdings Could Mean 11% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-21 10:39:22
Sarepta Therapeutics (NASDAQ:SRPT) Given New $17.00 Price Target at Bank of America
Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price objective lifted by Bank of America to $17.00 in a research note issued to investors on Wednesday,Benzinga reports. They currently have an underperform rating on the biotechnology company’s stock. Other equities analysts have also issued reports about the company. Baird R W lowered Sarepta Therapeutics from […] - 2025-08-21 04:58:48
Sarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $12.00
Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price objective hoisted by Deutsche Bank Aktiengesellschaft to $12.00 in a research note released on Friday,Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a sell rating on the biotechnology company’s stock. Other research analysts have also issued reports about the stock. TD Cowen lowered shares of Sarepta Therapeutics […] - 2025-08-18 03:06:45
Vanguard Group Inc. Decreases Stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Vanguard Group Inc. lowered its position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 0.6% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 9,032,613 shares of the biotechnology company’s stock after selling 52,843 shares during the quarter. Vanguard Group Inc. owned about 0.09% […] - 2025-08-14 04:37:10
Stocks Rally on Positive Tariff News ad Rate Cut Hopes
The S&P 500 Index ($SPX ) (SPY ) today is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.71%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures... - 2025-08-07 18:57:35
Stocks Rally on Positive Tariff News ad Rate Cut Hopes
The S&P 500 Index ($SPX ) (SPY ) today is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.71%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures... - 2025-08-07 13:11:34
Stocks Rally on Positive Tariff News ad Rate Cut Hopes
The S&P 500 Index ($SPX ) (SPY ) today is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.71%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures... - 2025-08-07 12:48:17
Stocks Rally on Positive Tariff News ad Rate Cut Hopes
The S&P 500 Index ($SPX ) (SPY ) today is up +0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.71%. September E-mini S&P futures (ESU25 ) are up +0.53%, and September E-mini Nasdaq futures... - 2025-08-07 12:41:53
Barclays Upgrades Sarepta Therapeutics (NASDAQ:SRPT) to “Equal Weight”
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by analysts at Barclays from an “underweight” rating to an “equal weight” rating in a research report issued to clients and investors on Tuesday, MarketBeat.com reports. The firm currently has a $22.00 target price on the biotechnology company’s stock. Barclays‘s price objective indicates a potential upside […] - 2025-07-31 05:26:59
Sarepta Therapeutics (NASDAQ:SRPT) Stock Rating Upgraded by Barclays
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by research analysts at Barclays from an “underweight” rating to an “equal weight” rating in a report released on Tuesday, MarketBeat Ratings reports. The brokerage presently has a $22.00 target price on the biotechnology company’s stock. Barclays‘s price target would indicate a potential upside of 35.38% […] - 2025-07-31 05:26:59
Sarepta Therapeutics (NASDAQ:SRPT) Upgraded to Equal Weight at Barclays
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by stock analysts at Barclays from an “underweight” rating to an “equal weight” rating in a research note issued on Tuesday, Marketbeat reports. The brokerage presently has a $22.00 price target on the biotechnology company’s stock. Barclays‘s price objective points to a potential upside of 31.34% […] - 2025-07-31 05:26:59
BMO Capital Markets Forecasts Strong Price Appreciation for Sarepta Therapeutics (NASDAQ:SRPT) Stock
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target hoisted by BMO Capital Markets from $25.00 to $50.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “market perform” rating on the biotechnology company’s stock. BMO Capital Markets’ price objective would indicate a potential upside of 198.51% from the stock’s […] - 2025-07-31 05:26:58
William Blair Reaffirms “Outperform” Rating for Sarepta Therapeutics (NASDAQ:SRPT)
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “outperform” rating reissued by investment analysts at William Blair in a research report issued on Tuesday,RTT News reports. Other equities analysts have also recently issued reports about the stock. Bank of America reaffirmed an “underperform” rating on shares of Sarepta Therapeutics in a report on […] - 2025-07-31 05:26:58
Sarepta Therapeutics (NASDAQ:SRPT) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price objective hoisted by equities researchers at Morgan Stanley from $15.00 to $20.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the biotechnology company’s stock. Morgan Stanley’s price target suggests a potential upside of 19.40% from the stock’s […] - 2025-07-31 03:02:52
HC Wainwright Reaffirms Sell Rating for Sarepta Therapeutics (NASDAQ:SRPT)
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “sell” rating restated by analysts at HC Wainwright in a note issued to investors on Tuesday, MarketBeat.com reports. A number of other equities research analysts also recently commented on SRPT. Piper Sandler reduced their price objective on shares of Sarepta Therapeutics from $32.00 to $18.00 […] - 2025-07-31 03:02:51
Sarepta Therapeutics (NASDAQ:SRPT) Stock Rating Upgraded by JPMorgan Chase & Co.
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by equities researchers at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage currently has a $24.00 target price on the biotechnology company’s stock. JPMorgan Chase & Co.‘s price target […] - 2025-07-31 03:02:51
Stocks Retreat Ahead of Results from Wednesday's FOMC Meeting
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.21%. September E-mini S&P futures (ESU25 ) fell -0.30%, and September E-mini Nasdaq futures (NQU25... - 2025-07-30 12:49:47
Stocks Retreat Ahead of Results from Wednesday's FOMC Meeting
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.21%. September E-mini S&P futures (ESU25 ) fell -0.30%, and September E-mini Nasdaq futures (NQU25... - 2025-07-30 08:23:02
Sarepta Therapeutics (NASDAQ:SRPT) Earns “Underperform” Rating from Needham & Company LLC
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “underperform” rating reaffirmed by Needham & Company LLC in a report issued on Monday,Benzinga reports. Several other equities analysts have also recently issued reports on SRPT. Scotiabank raised Sarepta Therapeutics from a “sector perform” rating to a “sector outperform” rating and set a $80.00 price […] - 2025-07-30 04:54:53
Barclays Downgrades Sarepta Therapeutics (NASDAQ:SRPT) to Strong Sell
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was downgraded by equities research analysts at Barclays from a “hold” rating to a “strong sell” rating in a report released on Monday, MarketBeat Ratings reports. Other research analysts have also recently issued research reports about the stock. HC Wainwright reaffirmed a “sell” rating on shares of Sarepta […] - 2025-07-30 04:54:51
Stocks Retreat Ahead of Results from Wednesday's FOMC Meeting
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.21%. September E-mini S&P futures (ESU25 ) fell -0.30%, and September E-mini Nasdaq futures (NQU25... - 2025-07-30 03:41:41
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Up Following Analyst Upgrade
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) shares gapped up before the market opened on Tuesday after Barclays upgraded the stock from an underweight rating to an equal weight rating. The stock had previously closed at $13.86, but opened at $18.23. Barclays now has a $22.00 price target on the stock. Sarepta Therapeutics shares […] - 2025-07-30 02:14:47
Strong Earnings and Trade Deal Optimism Bolster Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.56%. September E-mini S&P futures (ESU25 ) are up +0.15%, and September E-mini Nasdaq futures... - 2025-07-29 20:49:20
Stocks Slide in Afternoon Session
The S&P 500 Index ($SPX ) (SPY ) today is down -0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.25%. After starting off the day stronger, the 3 major stock indxes are in the... - 2025-07-29 20:19:00
Stocks Supported by Strong Earnings and Trade Deal Optimism
The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. September E-mini S&P futures (ESU25 ) are up +0.03%, and September E-mini Nasdaq futures... - 2025-07-29 14:38:53
Stocks Supported by Strong Earnings and Trade Deal Optimism
The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. September E-mini S&P futures (ESU25 ) are up +0.03%, and September E-mini Nasdaq futures... - 2025-07-29 14:12:43
Strong Earnings and Trade Deal Optimism Bolster Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.56%. September E-mini S&P futures (ESU25 ) are up +0.15%, and September E-mini Nasdaq futures... - 2025-07-29 14:12:42

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc SRPT holdings

DateNumber of SRPT Shares HeldBase Market Value of SRPT SharesLocal Market Value of SRPT SharesChange in SRPT Shares HeldChange in SRPT Base ValueCurrent Price per SRPT Share HeldPrevious Price per SRPT Share Held
2025-11-12 (Wednesday)34,557SRPT holding decreased by -114USD 622,026SRPT holding decreased by -1359USD 622,026-114USD -1,359 USD 18 USD 17.98
2025-11-11 (Tuesday)34,671USD 623,385SRPT holding increased by 24617USD 623,3850USD 24,617 USD 17.98 USD 17.27
2025-11-10 (Monday)34,671USD 598,768SRPT holding decreased by -12482USD 598,7680USD -12,482 USD 17.27 USD 17.63
2025-11-07 (Friday)34,671USD 611,250SRPT holding decreased by -346USD 611,2500USD -346 USD 17.63 USD 17.64
2025-11-06 (Thursday)34,671SRPT holding decreased by -114USD 611,596SRPT holding decreased by -37840USD 611,596-114USD -37,840 USD 17.64 USD 18.67
2025-11-05 (Wednesday)34,785SRPT holding decreased by -1368USD 649,436SRPT holding increased by 63757USD 649,436-1,368USD 63,757 USD 18.67 USD 16.2
2025-11-04 (Tuesday)36,153USD 585,679SRPT holding decreased by -298262USD 585,6790USD -298,262 USD 16.2 USD 24.45
2025-11-03 (Monday)36,153SRPT holding decreased by -228USD 883,941SRPT holding increased by 10433USD 883,941-228USD 10,433 USD 24.45 USD 24.01
2025-10-31 (Friday)36,381USD 873,508SRPT holding increased by 27650USD 873,5080USD 27,650 USD 24.01 USD 23.25
2025-10-30 (Thursday)36,381USD 845,858SRPT holding decreased by -7276USD 845,8580USD -7,276 USD 23.25 USD 23.45
2025-10-29 (Wednesday)36,381USD 853,134SRPT holding decreased by -28014USD 853,1340USD -28,014 USD 23.45 USD 24.22
2025-10-28 (Tuesday)36,381SRPT holding increased by 342USD 881,148SRPT holding increased by 34231USD 881,148342USD 34,231 USD 24.22 USD 23.5
2025-10-27 (Monday)36,039USD 846,917SRPT holding increased by 24867USD 846,9170USD 24,867 USD 23.5 USD 22.81
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SRPT by Blackrock for IE00B3VWM098

Show aggregate share trades of SRPT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-114 18.000* 65.05 Profit of 7,416 on sale
2025-11-06SELL-114 17.640* 66.03 Profit of 7,527 on sale
2025-11-05SELL-1,36818.80016.580 16.802USD -22,985 66.28 Profit of 67,680 on sale
2025-11-03SELL-22824.55022.670 22.858USD -5,212 66.76 Profit of 10,009 on sale
2025-10-28BUY34224.22024.400 24.382USD 8,339 67.68
2025-10-24SELL-11422.81023.430 23.368USD -2,664 68.16 Profit of 5,106 on sale
2025-10-15BUY68422.20022.260 22.254USD 15,222 69.95
2025-10-02BUY11422.35023.420 23.313USD 2,658 70.49
2025-09-30BUY22819.27019.340 19.333USD 4,408 71.07
2025-09-11BUY45217.91017.950 17.946USD 8,112 72.65
2025-08-21SELL-11320.06020.120 20.114USD -2,273 72.96 Profit of 5,971 on sale
2025-07-31BUY33916.42017.580 17.464USD 5,920 73.61
2025-07-28SELL-11313.86014.040 14.022USD -1,584 74.68 Profit of 6,855 on sale
2025-06-30SELL-22617.10017.520 17.478USD -3,950 81.39 Profit of 14,445 on sale
2025-06-25SELL-11317.46018.880 18.738USD -2,117 82.74 Profit of 7,232 on sale
2025-06-20SELL-22620.08020.880 20.800USD -4,701 84.10 Profit of 14,305 on sale
2025-05-23BUY11337.90038.410 38.359USD 4,335 92.28
2025-05-19SELL-11337.94038.360 38.318USD -4,330 94.11 Profit of 6,305 on sale
2025-05-15SELL-33935.27035.700 35.657USD -12,088 95.13 Profit of 20,162 on sale
2025-05-12SELL-11336.37039.210 38.926USD -4,399 96.73 Profit of 6,532 on sale
2025-05-09SELL-11336.27039.660 39.321USD -4,443 97.28 Profit of 6,549 on sale
2025-04-30SELL-11362.40062.510 62.499USD -7,062 100.27 Profit of 4,269 on sale
2025-04-24SELL-22661.76061.910 61.895USD -13,988 101.86 Profit of 9,031 on sale
2025-04-22BUY1,47859.31059.330 59.328USD 87,687 102.73
2025-04-17SELL-10953.79055.490 55.320USD -6,030 104.28 Profit of 5,336 on sale
2025-04-15SELL-32754.42056.340 56.148USD -18,360 105.37 Profit of 16,095 on sale
2025-04-14SELL-32754.63054.640 54.639USD -17,867 105.92 Profit of 16,770 on sale
2025-04-09SELL-43655.65057.700 57.495USD -25,068 107.75 Profit of 21,912 on sale
2025-04-07SELL-76352.40055.170 54.893USD -41,883 109.07 Profit of 41,341 on sale
2025-04-04SELL-1,09054.43059.450 58.948USD -64,253 109.72 Profit of 55,339 on sale
2025-03-31BUY10963.82067.470 67.105USD 7,314 111.44
2025-03-19SELL-21879.97080.980 80.879USD -17,632 115.48 Profit of 7,542 on sale
2025-03-14SELL-65497.190100.000 99.719USD -65,216 116.52 Profit of 10,990 on sale
2025-03-13SELL-21898.370100.010 99.846USD -21,766 116.78 Profit of 3,692 on sale
2025-03-12SELL-3,70699.770102.400 102.137USD -378,520 117.03 Profit of 55,190 on sale
2025-03-07SELL-218103.030104.850 104.668USD -22,818 117.75 Profit of 2,852 on sale
2025-03-06SELL-327105.560107.230 107.063USD -35,010 117.94 Profit of 3,556 on sale
2025-03-03SELL-109101.220107.350 106.737USD -11,634 118.62 Profit of 1,295 on sale
2025-02-28SELL-654106.750108.480 108.307USD -70,833 118.81 Profit of 6,870 on sale
2025-02-26SELL-109106.860109.550 109.281USD -11,912 119.28 Profit of 1,090 on sale
2025-02-25SELL-327106.950107.110 107.094USD -35,020 119.49 Profit of 4,055 on sale
2025-02-18BUY545105.350106.100 106.025USD 57,784 120.72
2025-02-13BUY109109.460110.110 110.045USD 11,995 121.45
2025-02-12BUY109109.810110.340 110.287USD 12,021 121.69
2025-02-11BUY327109.680111.590 111.399USD 36,427 121.94
2025-02-06BUY981112.110119.270 118.554USD 116,301 122.59
2025-01-27BUY109116.890119.440 119.185USD 12,991 124.09
2024-12-30BUY545121.190121.630 121.586USD 66,264 124.56
2024-12-06BUY436128.170129.060 128.971USD 56,231 124.22
2024-12-05BUY109126.280127.870 127.711USD 13,920 124.15
2024-12-04BUY545126.530127.960 127.817USD 69,660 124.07
2024-11-29BUY545133.340138.810 138.263USD 75,353 123.46
2024-11-27BUY436137.940138.100 138.084USD 60,205 122.21
2024-11-26BUY109130.500131.000 130.950USD 14,274 121.83
2024-11-21BUY545110.500111.780 111.652USD 60,850 123.20
2024-11-20BUY327110.860111.380 111.328USD 36,404 123.89
2024-11-18BUY1,308104.670105.980 105.849USD 138,450 126.17
2024-11-12BUY872114.320118.730 118.289USD 103,148 126.96
2024-11-08BUY545121.610121.960 121.925USD 66,449 127.34
2024-11-07BUY1,620120.420133.000 131.742USD 213,422 127.87
2024-11-06BUY216127.970128.320 128.285USD 27,710 127.87
2024-10-31BUY108126.000128.190 127.971USD 13,821 129.63
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SRPT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19983,56911,5822,229,35644.1%
2025-09-181,090,47513,2562,892,18137.7%
2025-09-171,084,43212,6462,880,08537.7%
2025-09-16894,02124,7942,572,51634.8%
2025-09-15965,39017,4131,966,97649.1%
2025-09-12653,9584,4501,496,52443.7%
2025-09-111,072,91220,7792,821,71038.0%
2025-09-101,151,23526,9382,519,73145.7%
2025-09-09912,3845,7001,971,30846.3%
2025-09-081,691,08614,2363,124,45754.1%
2025-09-05983,68832,9292,352,17841.8%
2025-09-04914,1254,0941,995,50145.8%
2025-09-031,510,13728,0813,442,47743.9%
2025-09-021,295,4201,7422,645,87349.0%
2025-08-291,216,3688,5982,467,99249.3%
2025-08-281,059,0254,6452,463,62643.0%
2025-08-271,514,6362132,902,51252.2%
2025-08-261,565,99849,8953,527,43544.4%
2025-08-252,838,9585,2296,270,84045.3%
2025-08-221,981,78231,8414,688,70342.3%
2025-08-214,086,13090,9177,046,33158.0%
2025-08-201,278,7054,5102,928,74143.7%
2025-08-19876,3141,4942,229,42439.3%
2025-08-181,204,4303,0102,779,04043.3%
2025-08-151,705,8679,1864,100,04041.6%
2025-08-141,349,4418353,381,57939.9%
2025-08-131,545,26520,7605,282,33129.3%
2025-08-121,305,8382,5073,231,12540.4%
2025-08-112,168,6739,1525,077,98542.7%
2025-08-082,133,50314,9324,694,28445.4%
2025-08-073,771,97442,4797,573,97949.8%
2025-08-062,783,5034,4765,375,05551.8%
2025-08-051,594,8466763,432,44546.5%
2025-08-044,127,0573,7787,480,14955.2%
2025-08-012,097,7514,0354,221,31849.7%
2025-07-313,263,53232,1437,100,48946.0%
2025-07-308,885,53612,37218,507,33748.0%
2025-07-2917,694,15467,60830,461,99558.1%
2025-07-284,761,652590,3969,578,71049.7%
2025-07-252,445,819120,8785,876,92241.6%
2025-07-249,985,202652,75020,571,46348.5%
2025-07-231,525,8395,3074,030,26637.9%
2025-07-224,478,481383,13310,024,47644.7%
2025-07-213,426,18878,3209,225,50637.1%
2025-07-1811,983,277545,93629,286,07140.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.